Weighing the data on diet and prostate cancer

per Zlotta, Alexandre
Publicat 2008

What is the future of virtual cystoscopy in urology?

per Zlotta, Alexandre R.
Publicat 2011

Bladder cancer: Validating what we’ve got

per Zlotta, Alexandre R.
Publicat 2013

What’s new in bladder cancer research?

per Zlotta, Alexandre R.
Publicat a Can Urol Assoc J (2016)

Novel use of an old compound? Urologist‐led Bacille Calmette–Guérin vaccine trials in the prevention of coronavirus disease 2019

per Zlotta, Alexandre R.
Publicat a BJU Int (2020)

Treatment of bladder cancer in the elderly

per Erlich, Annette, Zlotta, Alexandre R.
Publicat a Investig Clin Urol (2016)

The use of intravesical BCG in urothelial carcinoma of the bladder

per Alhunaidi, Omar, Zlotta, Alexandre R
Publicat a Ecancermedicalscience (2019)

Urothelial Bladder Cancer Urinary Biomarkers

per Noon, Aidan P, Zlotta, Alexandre R
Publicat a EJIFCC (2014)

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy

per Neill, Mischel G, Shahani, Rohan, Zlotta, Alexandre R
Publicat 2008

The burden of prostate cancer in Canada

per Fradet, Yves, Klotz, Laurence, Trachtenberg, John, Zlotta, Alexandre
Publicat 2009

Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscleinvasive bladder cancer? The jury is still out bu...

per Tan, Guan Hee, Kuk, Cynthia, Zlotta, Alexandre R.
Publicat a Can Urol Assoc J (2020)

The management of BCG failure in non-muscle-invasive bladder cancer: an update

per Zlotta, Alexandre R., Fleshner, Neil E., Jewett, Michael A.
Publicat 2009

Gleason grading controversies: what the chemoprevention trials have taught us

per Klotz, Laurence, Drachenberg, Darrel, Fradet, Yves, Saad, Fred, Trachtenberg, John, Zlotta, Alexandre
Publicat 2009

Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study

per Toren, Paul, Margel, David, Kulkarni, Girish, Finelli, Antonio, Zlotta, Alexandre, Fleshner, Neil
Publicat 2013

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not

per Hemminki, Otto, Perlis, Nathan, Bjorklund, Johan, Finelli, Antonio, Zlotta, Alexandre R., Hemminki, Akseli
Publicat a Eur Urol Open Sci (2020)

The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy

per Al Edwan, Ghazi, Bhindi, Bimal, Margel, David, Chadwick, Karen, Finelli, Antonio, Zlotta, Alexandre, Trachtenberg, John, Fleshner, Neil
Publicat a Can Urol Assoc J (2016)

Does nerve-sparing radical prostatectomy increase the risk of positive surgical margins and biochemical progression?

per Alkhateeb, Sultan Saud, Alibhai, Shabbir M., Finelli, Antonio, Fleshner, Neil E., Jewett, Michael A., Zlotta, Alexandre R., Trachtenberg, John
Publicat 2010

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

per Kamdar, Shivani, Isserlin, Ruth, Van der Kwast, Theodorus, Zlotta, Alexandre R., Bader, Gary D., Fleshner, Neil E., Bapat, Bharati
Publicat a Clin Epigenetics (2019)

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

per Abufaraj, Mohammad, Dalbagni, Guido, Daneshmand, Siamak, Horenblas, Simon, Kamat, Ashish M., Kanzaki, Ryu, Zlotta, Alexandre R., Shariat, Shahrokh F.
Publicat a Eur Urol (2017)

Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO C...

per Seah, Jo-An, Blais, Normand, North, Scott, Rahim, Yasmin, Ruether, Dean, Black, Peter C., Zlotta, Alexandre R., Wood, Lori, Sridhar, Srikala S.
Publicat 2013